Genzyme Molecular Oncology (GMO) provided research support to KWK and has licensed the SAGE technology¹ from The Johns Hopkins University for commercial purposes; the technology is freely available to academia for research purposes. The University and researchers (KWK and BV) have a financial interest in GMO, the arrangements for which are managed by the University in accordance with its conflict of interest policies.

¹Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW (1995). Serial Analysis Of Gene Expression. Science 270, 484-487